Most Favored Nation Pricing is Again – With a Vengeance
On September 15, 2020, I posted an article on this weblog entitled “Trump Embraces Worldwide Reference Pricing in Government Order,”...
Biotechnology & Pharma
Vor Bio winding down as a number of biotechs downsize
The challenges dealing with biotechs amid the continued monetary fallout have resulted within the winding down of 1 US biotech,...
Amgen’s Tepezza granted advertising and marketing authorisation within the UK
Teprotumumab permitted as first focused remedy for thyroid eye illness The UK’s Medicines and Healthcare merchandise Regulatory Company (MHRA) has...
Prime 10 Finest-Promoting Gene Therapies
With apologies to Charles Dickens, the marketplace for gene therapies could be summed up as being in “the very best...
College Hospitals Seidman Most cancers Middle Secures Funding to Improve
CLEVELAND — Most cancers sufferers endure a fancy array of signs all through their therapy journey, a lot of which...
New CBER Director Appointed
Textual content signal displaying Trade Information. Enterprise picture textual content delivering information to most people or a goal public |...
“Know the One You’re Dancing With”
Drug Enforcement Administration (“DEA”) civil financial settlements involving listed chemical compounds that don't embrace pseudoephedrine are uncommon. Much more scarce...
FDA determination on oral Wegovy coming in This autumn
Novo Nordisk has pulled forward within the race to carry the primary oral GLP-1 for weight problems to market. The...
Leqembi dosing proposal for Alzheimer’s remedy validated by MHRA
Software seeks lowered infusion frequency to help affected person flexibility Eisai Europe and Biogen Idec have introduced the validation of...
Second Time’s the Appeal for Abeona’s Gene Remedy
“Third time’s the appeal,” the outdated saying goes, however for Abeona Therapeutics (NASDAQ: ABEO), the second time round proved profitable...
